Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Joshi A; Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India.; Karkinos Foundation, Mumbai, Maharashtra, 400086, India.
Subjects: Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology ; Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/drug effects
-
Source:
Medical oncology (Northwood, London, England) [Med Oncol] 2024 Aug 06; Vol. 41 (9), pp. 219. Date of Electronic Publication: 2024 Aug 06.Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium:
Record details
-
Authors :
Xu Z; Zhengzhou Research Base, State Key Laboratory of Cotton Biology, School of Agricultural Sciences, Zhengzhou University, Zhengzhou, 450000, China.; Zhai Y
Subjects: Nicotiana* ; Taxoids*/Taxoids*/Taxoids*/metabolism ; Taxoids*/Taxoids*/Taxoids*/pharmacology
-
Source:
Plant cell reports [Plant Cell Rep] 2024 Mar 12; Vol. 43 (4), pp. 94. Date of Electronic Publication: 2024 Mar 12.Publisher: Springer Country of Publication: Germany NLM ID: 9880970 Publication Model: Electronic Cited Medium: Internet
Record details
-
Authors :
Strobbe G; Pole produits de santé, Service de pharmacie, Centre Oscar Lambret, 3, rue Frédéric Combemale, 59020, Cedex BP307, Lille, France. .; Gaboriau L
Subjects: Histamine H2 Antagonists*/Histamine H2 Antagonists*/Histamine H2 Antagonists*/supply & distribution ; Paclitaxel*/Paclitaxel*/Paclitaxel*/adverse effects ; Antineoplastic Agents, Phytogenic*/Antineoplastic Agents, Phytogenic*/Antineoplastic Agents, Phytogenic*/adverse effects
-
Source:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2023 Sep; Vol. 79 (9), pp. 1229-1238. Date of Electronic Publication: 2023 Jul 13.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Hamm C; University of Windsor, Windsor, ON, N9B 3P4, Canada. .; Western University, Windsor, ON, N9B 3P4, Canada. .
Subjects: Anthracyclines/Anthracyclines/Anthracyclines/*administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Bridged-Ring Compounds/Bridged-Ring Compounds/Bridged-Ring Compounds/*administration & dosage
-
Source:
Medical oncology (Northwood, London, England) [Med Oncol] 2022 Feb 01; Vol. 39 (4), pp. 49. Date of Electronic Publication: 2022 Feb 01.Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium:
Record details
-
Authors :
Wang Q; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.; Central Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Subjects: Drug Resistance, Neoplasm*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Autophagy/Autophagy/Autophagy/*drug effects
-
Source:
International urology and nephrology [Int Urol Nephrol] 2018 Apr; Vol. 50 (4), pp. 675-686. Date of Electronic Publication: 2018 Feb 19.Publisher: Springer Country of Publication: Netherlands NLM ID: 0262521 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Tambo Y; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.; Hosomi Y
Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*drug therapy
-
Source:
Investigational new drugs [Invest New Drugs] 2017 Apr; Vol. 35 (2), pp. 217-226. Date of Electronic Publication: 2017 Jan 30.Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium:
Record details
